Dipharma Arzneimittel GmbH

Pharmaceutical Companies · Limburg-Weilburg

Dipharma Arzneimittel GmbH is a pharmaceutical company based in Limburg-Weilburg, Hesse, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Dipharma Arzneimittel GmbH – Address & Contact

Address

Offheimer Weg 33
65549 Limburg-Weilburg

Dipharma Arzneimittel GmbH Overview

Dipharma Arzneimittel GmbH is a pharmaceutical company based in Limburg-Weilburg, Hessen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Dipharma Arzneimittel GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

About Dipharma Arzneimittel GmbH

Dipharma medicines GmbH ist das deutsche Tochterunternehmen der Dipharma SA .

Location & Contact

Dipharma Arzneimittel GmbH can be reached at the following address: Offheimer Weg 33, 65549 Limburg-Weilburg – Phone: 064312843201. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Hessen or all Pharmaunternehmen in Germany on Sanoliste.

Pharmazeutische Regulierung in Deutschland

Pharmaceutical companies such as Dipharma Arzneimittel GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.

Arzneimittelversorgung & Marktumfeld

With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Dipharma Arzneimittel GmbH, based in Limburg-Weilburg, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.

Pharmastandort Hessen

Hessen is a significant pharmaceutical location in Germany. Companies such as Dipharma Arzneimittel GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.

Frequently asked questions about Dipharma Arzneimittel GmbH

What does Dipharma Arzneimittel GmbH do?

Dipharma Arzneimittel GmbH is a pharmaceutical company based in Limburg-Weilburg that develops, manufactures or distributes pharmaceutical products. The company is active in the German healthcare market.

Where is Dipharma Arzneimittel GmbH located?

Dipharma Arzneimittel GmbH is headquartered in Limburg-Weilburg, Germany. More information can be found on the company's website.

What products does Dipharma Arzneimittel GmbH distribute?

Dipharma Arzneimittel GmbH is active in the pharmaceutical sector. Detailed information on the products offered and therapeutic areas can be found on the company's website or via the contact details provided.

Pharmaceutical Companies in Hessen

All Pharmaceutical Companies in Hessen on Sanoliste — or discover all categories by federal state.

Last updated: 17.03.2026 · Category: Pharmaceutical Companies